Author: Urenus

Drops

Ingredients

• Bone 10X/30X/200X
• Calcarea fluorica 12X/30X/200X
• Calcarea carbonica 12X/30X/200X
• Calcarea phosphorica 12X/30X/200X
• Calcitonin 6X
• L-isoleucine 3X
• L-leucine 3X
• L-lysine 3X
• L-methionine 3X
• L-phenylalanine 3X
• L-threonine 3X
• L-tryptophan 3X
• L-valine 3X
• Parathyroid gland 10X/30X/200X

Uses

Adjuvant treatment of osteoporosis

Directions

20 drops twice a day for two months at least

Package size

30 ml/1.0 fl. Oz. bottle

Most common combinations

Osteobios + Guna-Fem: basic treatment of perimenopausal osteoporosis.

Osteobios + Guna-Cell + Guna-Matrix: remodeling of bone matrix.

Osteobios + Guna-Arthro: osteoporosis and osteochondrosis.

Rational structure according to the Guna-Method

Lines of action: Modulation of osteoclast and stimulation of osteoblast activity; Regulation of bone metabolism; Trophic action on bones

Actions:

• Stimulation of enzyme mechanisms supervising metabolic processes involving Ca salts and their fixation.
• Modulation of parathyroid function and relevant parathormone synthesis and consequent reduction of bone reabsorption**
• Stimulation of the fixation of Ca in bones*
• Synergical action involving trophic stimulation* and optimization of amino acid cell absorption**

Component groups:

• Calcarea carb. 12/30/200X; Calcarea fluor. 12/30/200X; Calcarea phosph. 12/30/200X
• Calcitonin 6X*; Parathyroid gland10/30/200X**
• Bone, 10/30/200X*; Essential amino acids 3X**

Product link: https://urenus.com/en-us/products/osteobios-drops-30ml-drops

Drops

Ingredients

• Aspergillus niger 12X/30X/200X
• Candida albicans 12X/30X/200X
• DL-malic acid 6X/12X/30X
• Hydrocotyle asiatica 6X
• Mercurius corrosivus 6X
• Mucor mucedo 12X/30X/200X
• Natrum oxalaceticum 6X/12X/30X
• Pink trumpet tree 4X
• Sulfur 6X

Uses

Treatment of mucocutaneous mycosis. co-adjuvant treatment of diseases secondary to mycosis.

NOTE: Micox is recommended in association with Eubioflor.

For better results yeasts, refined sugar, pork and other foods that may cause intolerance should be avoided.

Directions

10 drops 3 times a day for the first two months. Maintenance: 10 drops a day also over extended periods of time.

Package size

30 ml/1.0 fl. Oz. bottle

Most common combinations

Micox + Citomix : chronic, recurrent and persistent mucocutaneous mycosis.

Micox + Eubioflor: mycosis of possible dysbiotic origin.

Rational structure according to the Guna-Method

Lines of action: Draining action; Immune reaction; Metabolic action

Actions:

• Strengthening of specific* and aspecific** immune reaction
• Mesenchymal detoxication* and connective tissue and lympho-hematic drainage**
• Alkalinisation of the connective tissue

Component groups:

• Mucor Mucedo 12/30/200X*; Candida Albicans 12/30/200X*; Aspergillus Niger 12/30/200X*; Pink Trumpet Tree 4X**
• Sulfur 6X*; Hydrocotyle Asiatica 6X**; Mercurius Corr. 6X**
• Natrum Oxalaceticum 6/12/30X; Dl Malic Acid 6/12/30X

Product link: https://urenus.com/en-us/products/micox-30ml-drops

The Metatox range comprises four combinations of homeopathic and gemmo-phytotherapeutic remedies as adjuvant treatment during withdrawal from smoking, alcohol, etc., and in slimming diets.

Composition

Stevia D1, Solidago virga aurea TM, Hieracium pilosella D1, Juniperus com-munis gemmae D1, Berberis vulgaris D1, Schrophularia nodosa D3, Apis mel-lifica D4, Galphimia glauca D3, Adrenalinum 4CH, Gl. thyroidea 4CH, Chelidonium majus D3, Lycopodium D3, Natrium muriaticum D9, Argentum nitricum D9, Calcium carbonicum D10, Syzygium jamb. D1. Contains alco-hol (30%).

Indications

Improves metabolic activity, regulates hypoglycemia, helps elimination of fluids excess, improves the body energy.

Dosage

30 drops at least 4 times a day.

Package size

30 ml bottle with drop counter. For oral use.

Product link: https://urenus.com/en-us/products/metatox-04-drainage-30ml-drops

Composition

Leucin D6, Isoleucin D8, Valine D20, Tryptophan D8, Phenylalanine D8, Tyrosine D8, Treonine D8, Methionine D8, Cysteine D8, Histidine D8, Arginine D5, Ornithine hydrochloride D4, Proline D4, Serine D14, Alanine D14, Ubiquinone D6.

Indications

Stimulation of muscle anabolism. Reduction of muscle catabolism. Stimulation of oxidative phosphorylation in muscle cells. Reduced release of lactic acid.

Dosage

• Granules: 3-5 granules 1 hour before starting training
• 3-5 granules immediately before starting training
• 3-5 granules within 45 minutes from end of training

Injectable ampoules:1 ampoule before and 1 after completing the training session via im. or sc. . The s.c. administration may be used to stimulate a specific group of muscles.

Package size

Tube containing 4 g of granules.

Pack containing 10 ampoules of 1 ml

Product link: https://urenus.com/en-us/products/olympia-4gm-granules

Omega Formula™ is a food supplement that, thanks to its specific synergetic formulation, helps to protect the cardiovascular system from the various risk factors.

Omega Formula™, containing red yeast rice standardized to Monacolin K (10 mg), micronised seeds of the Baobab fruit – Adansonia digitata L.- (containing Omega3-Omega6-Omega9 in a balanced ratio), Vitamin B6 and Folic Acid, is recommended in cases of: overweight, obesity, hypercholesterolaemia, hypertriglyceridaemia and hyperhomocysteinaemia secondary to dietary imbalance. Omega Formula™’s nutritional ingredients boast high bioavailability: as they pass through the stomach, its polyunsaturated fatty acids are protected naturally by the fibres contained in the Baobab seeds.

Omega Formula™ ingredients are not obtained from genetically-modified organisms (GMO-free) and they do not contain lactose.

Regular use of Omega Formula™, combined with a balanced diet and a healthy lifestyle helps to:

• maintain the correct ratio between LDL and HDL cholesterol levels
• normalise the levels of triglycerides in the blood
• balance homocysteine levels.

How it works

Red yeast rice: Is obtained from the natural fermentation of rice (Oryza sativa L.) with a yeast, Monascus purpureus, which produces Mevinoline and Monacolin K: these molecules have been seen to significantly favour the reduction in LDL cholesterol and triglyceride levels, without side effects. Monacolin K is a natural inhibitor of the enzyme HMG-CoA reductase, which is responsible for the production of mevalonic acid, a key reaction in the formation of endogenous cholesterol.

Micronised Baobab fruit seed: Thanks to the special production technique, it keeps it unaltered the Omega3-Omega6-Omega9 fibre rich in and phytosterols. One of the most important characteristics of Omega Formula™ is the amount of Omega6, which is involved in reducing the LDL/HDL ratio.

Vitamin B6: 30% of the elderly are vitamin B6- deficient and this deficiency is associated with an increased cardiovascular risk: the daily dose of Omega Formula™ provides more than 200% of the recommended daily intake, which helps to reduce cardiovascular risk factors.

Folic acid: Another important factor associated with cardiovascular risk is a rise in homocysteine levels: recent studies suggest that implementing the daily intake of folic acid through the diet and food supplementation has preventing effects. The daily dose of Omega Formula™ provides 150% the recommended daily intake of Folic Acid.

Cocoa: Given its polyphenol content, a cardiovascular protection action is attributed to cocoa extract.

Ingredients

Sweetener: sorbitol (from corn or wheat); Baobab (Adansonia digitata L.) micronised seed, red yeast rice (Monascus purpureus) dry extract standardized to 1.5% monacolin K, maltodextrins, unsweetened cocoa powder, flavouring, anti-caking agents: silicon dioxide, sodium carboxymethylcellulose, vegetable magnesium stearate; sweetener: sucralose; pyridoxine hydrochloride (vitamin B6), pteroylmonoglutamic acid (folate).

Directions

The recommended dose is 3 chewable tablets a day, 1 during or after each meal, depending on diet. Tablets should be chewed.

The recommended

daily dose for best results is 10 mg of Monacolin K from red yeast rice reparations, equal to 3 tablets a day.

Packaging

80 x 2 g chewable tablets – Net weight 160 g

Warnings and precautions

Store away from direct light, in a cool, dry place. The expiry date refers to the product correctly stored in its original and undamaged packaging. Do not exceed the recommended daily dose. Keep out of the reach of young children. Food supplements should not be considered as a substitute for a varied diet and a healthy lifestyle. Excessive use may produce laxative effects. Ask your doctor for advice on using the product. Do not use during pregnancy, breastfeeding and treatment with lipid-lowering drugs.

Most common combinations

Omega Formula + Gunamino Formula: body weight control.

Omega Formula + Vit Formula: diets deficient in essential nutrients.

Product link: https://urenus.com/en-us/products/omega-formula-80-tablets-of-2g

Pellets

Ingredients

• alpha-Ketoglutaricum acidum 6X alpha-Lipoicum acidum 6X
• Adenosintriphosphate 8X
• Ascorbic acid 4X
• Barium oxalsuccinate 6X
• Beta vulgaris 2X
• Cerium oxalicum 6X
• Cis-Aconitic acid 6X
• Coenzyme a 6X
• Cysteinum 6X
• Embryo extract 6X
• Fumaricum acidum 6X
• Ginseng 3X
• Glandula suprarenalis10X
• Lacticum acidum 8X
• Magnesium carbonate 2X
• Malic acid 6X
• Manganum phosphoricum 6X
• Muscle tissue 6X
• Natrum oxalaceticum 6X
• Natrum pyruvicum 6X
• Pyridoxinum hydrochloricum 6X
• Riboflavinum 6X
• Succinicum acidum 6X
• Thiaminum hydrochloricum 4X

Uses

Metabolic stimulation of muscle fiber cell; ATP synthesis improvement; Anaerobic threshold elevation; Reduction of lactic acidosis; and muscle fatigue control.

Directions

3 pellets 2-3 times a day. During sport training: 3 pellets 30 minutes before training.

Package size

Net Wt. 8 g/0.28 oz. 2 Tubes

Most common combinations

Omeosport + Guna-Matrix + Guna-Liver: liver drainage in patients suffering from serious lactic acidosis.

Omeosport + Guna-Cell: strengthening of the cell energy metabolism.

Rational structure according to the Guna-Method

Lines of action: Antitoxin action; Cell metabolism stimulation; Trophic stimulation; Anti-stress action

Actions:

• Stimulation to eliminate the muscle lactic acid by triggering antitoxinspecific enzymes
• Anabolic stimulation of the whole organism*
• Trophic and antidegenerative action on muscles**
• Oxidative phosphorylation increase
• Raising of anaerobic threshold
• Stimulation of adrenal gland function and consequent increase in catecholamines * Tonic-stimulating action**

Component groups:

• Lacticum Ac. 8X
• Beta vulgaris 2X; Vitamins Krebs Cycle Intermediate Catalysts
• Embryo 6X*; Muscle tissue 6X**
• Glandula suprarenalis, 10X*; Ginseng 3X**

Product link: https://urenus.com/en-us/products/omeosport-2-x-tubes-4gm-granules

Indications

Post-menopausal, senile and oestrogen-deficiency-induced atrophic vulvovaginitis. Oestrogen-deficiency-induced dyspareunia. Post-menopausal dyspareunia.

Components

Estradiol D6, Ovarium D6, Placenta suis D6, Embryo totalis suis D6

Clinical notes from homeopathic materia medica

Estradiol D6 in mild deficiencies, it regulates the physiological concentration of the hormone, compensating for the deficit and alleviating the consequent symptoms

• Ovarium suis activates ovarian function
• D6 Placenta stimulates peripheral blood flow, with a trophic

action on the tissues suis D6

Embryo totalis suis D6 revitalises the skin by improving vascularisation

Dosage and administration

Apply morning and evening for at least 2 months; then continue once a day and after coitus.

Package size

Pach containing 1 tube of 75 ml of cream and 2 cannules that make easy the vaginal application.

The cannules are reusable and easy to clean and wash.

Product link: https://urenus.com/en-us/products/natur-2-vaginal-cream

Collagen + cimicifuga

Sterile vials

Intended use

• Improve movement of the thoracic tract of the spine.
• Help muscle stretching.
• Help to support the muscle tissue in bad posture disorders.
• Soothe local pain, pain caused by movement and bad posture.

Directions

Therapeutic protocol: 2 treatments weekly for the first 2 weeks, 1 treatment weekly until improvement of symptoms (average 8-10 sessions). For chronic pathologies: go on with 1 treatment weekly for 1 month until improvement of symptoms, then 1 treatment monthly.

Periarticular injection technique (the site of application must be aseptic; insert the needle at 2-4 mm depth).

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to inject.

Instructions and possible combinations

MD-THORACIC may be used as a single treatment or mixed with other medical devices of the same range, in order to make a customised treatment according to clinical evolution. When a supportive treatment is needed for acute pain, MD-THORACIC can be associated with MD-NEURAL, MD-POLY and MD-MUSCLE (together with one or more than one of these).

Moreover, when a supportive treatment is needed for the connective tissue matrix or when the physiological aging process should be slowed down, MD-THORACIC can be associated with MD-MATRIX and MD-TISSUE.

It may also be used as mechanical support while treating the following diseases:

• Thoracic pain due to scoliosis (in association with MD-MUSCLE and MD-NEURAL)
• Thoracic pain due to thoracic long muscle trigger points

(in association with MD-MUSCLE)

• Pain due to thoracic spine osteophytosis (in association with MD-NEURAL)
• Pain from spinal osteoporosis (in association with MD-NEURAL and MD-MUSCLE)
• Mechanical imbalance (costo-vertebral facet joint syndrome) (in association with MD-NEURAL)
• Thoracic spinal ligament syndrome (in association with MD-NEURAL)
• Thoracic spinal nerve root pain (in association with MD-NEURAL).

Product link: https://urenus.com/en-us/products/md-thoracic-pack-of-10-ampoules-of-2ml

Collagen + viola

Sterile vials

Intended use

• Improve movement of the small joints of hand, foot and ankle.
• Help muscle stretching.
• Help to support the muscle tissue.
• Soothe local pain and pain caused by joint movement.

Directions

Therapeutic protocol: 1 treatment weekly for 10 consecutive weeks.

Periarticular injection technique (the site of application must be aseptic; insert the needle near the sacroiliac joint at 2-4 mm depth)

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to inject.

Intraarticular injection technique

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin. The application of a topical anaesthetic on the skin area to be treated is recommended.
• Needles: sterile 22 G.
• Syringes: 2 cc size, according to the volume of the solution to inject.

Ankle – Intraarticular approach

Medial approach. A 22 G needle is placed about 4 cm proximal and lateral to the distal end of the medial malleolus. The flexor hallucis longus tendon is just lateral to this point. The needle is directed 45 degrees posteriorly, slightly upward, and laterally.

Lateral approach. A 22 G needle is placed about 1 cm proximal and medial to the distal end of the lateral malleolus. The needle should be inserted 45 degrees posteriorly, slightly upward.

Instructions and possible combinations

MD-SMALL JOINTS may be used as a single treatment or mixed with other medical devices of the same range, in order to make a customised treatment according to clinical evolution.

When a supportive treatment is needed for acute pain, MD-SMALL JOINTS can be associated with MD-NEURAL, MD-POLY and MD-MUSCLE (together with one or more than one of these).

Moreover, when a supportive treatment is needed for the connective tissue matrix or when the physiological aging process should be slowed down, MD-SMALL JOINTS can be associated with MD-MATRIX and MD-TISSUE.

It may also be used as mechanical support while treating the following diseases:

• Osteoarthritis of the fingers
• Rhizoarthrosis of the thumb (Forestier disease)
• Arthrosis pain due to hammer toe
• Carpal-tunnel syndrome (in association with MD-NEURAL)
• De Quervain disease (in association with MD-NEURAL)
• Metatarsal pain
• Metatarsal pain accompanied by Morton’s neuroma (in association with MD-NEURAL)
• Rheumatoid arthritis of the hand/foot (in association with MD-POLY)
• Hand/Foot tendon pain due to prolonged immobilisation.

Product link: https://urenus.com/en-us/products/md-small-joints-pack-of-10-ampoules-of-2ml

Collagen + drosera

Sterile vials

Intended use

• Improve movement of the joints.
• Help muscle stretching.
• Help to support the muscle tissue in bad posture disorders.
• Soothe local pain, or pain caused by movement and bad posture.

Directions

Therapeutic protocol:1-2 treatments weekly for 10 consecutive weeks.

Periarticular injection technique (the site of application must be aseptic; insert the needle at 3-6 mm depth)

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to inject.

Intraarticular injection technique

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for skin.The application of a topical anaesthetic on the skin area to be treated is recommended.
• Needles: sterile 22 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to inject.

Instructions and possible combinations

MD-POLY may be used as a single treatment or mixed with other medical devices of the same range, in order to make a customised treatment according to clinical evolution.

When a supportive treatment is needed for the connective tissue matrix or when an antiaging action is necessary, MD-POLY can be used together with MD-MATRIX and MD-TISSUE. It may also be used as mechanical support while treating the following diseases:

• Small joints rheumatoid arthritis of hand and foot (in association with MD-SMALL JOINTS)
• Non-specific diffuse pain (in association with MD-NECK and MD-NEURAL)
• Costo-sternal syndrome (in association with MD-NEURAL)
• Chronic polyarthritis due to auto-immune diseases (e.g. Lupus erithematosus sistemicus) (in association with MD-NEURAL when nerve pain is dominant; in association with MD-MUSCLE when muscle pain is dominant)
• Breakbone fever (when nerve pain is dominant in association with MD-NEURAL; when muscle pain is dominant in association with MD-MUSCLE)
• Joint pain due to viral or protozoic disease (in association with another Guna medical device containing the same type of collagen contained in the joint to be treated)
• Joint pain due to cancer (chronic leukaemia, multiple myeloma) (in association with another Guna medical device containing the same type of collagen contained in the joint to be treated).

Product link: https://urenus.com/en-us/products/md-poly-pack-of-10-ampoules-of-2ml